Remimazolam decreased the incidence of early postoperative nausea and vomiting compared to desflurane after laparoscopic gynecological surgery.

Yuki HariShiho SatomiChiaki MurakamiSoshi NarasakiAtsushi MorioTakahiro KatoYasuo M TsutsumiNami KakutaKatsuya Tanaka

Published in: Journal of anesthesia (2022)

Remimazolam can reduce the incidence of PONV after laparoscopic gynecological surgery compared to general anesthesia with desflurane during the early postoperative period.

Keyphrases

minimally invasive
robot assisted
coronary artery bypass
patients undergoing
risk factors
surgical site infection
coronary artery disease